Zeleris, POM-V

Product Description

Description

Zeleris is a veterinary medicine used to treat cattle with bovine respiratory disease (BRD, a condition affecting the lungs) associated with a high temperature, which is due to the bacteria Mannheimia haemolytica, Pasteurella multocida and Histophilus somni. Zeleris contains the active substances florfenicol and meloxicam.

Florfenicol is a broad-spectrum antibiotic which stops bacteria from growing by blocking the activity of ribosomes, the part of the bacterial cells where proteins are produced.

Meloxicam belongs to a class of medicines called non-steroidal anti-inflammatory drugs (NSAIDs). Meloxicam acts by blocking an enzyme called cyclooxygenase which is involved in the production of prostaglandins. As prostaglandins are substances that trigger inflammation, pain, exudation (fluid that leaks out of blood vessels during an inflammation) and fever, meloxicam reduces these signs of disease.

NAME OF THE VETERINARY MEDICINAL PRODUCT

 Zeleris 400 mg/ml + 5 mg/ml solution for injection for cattle

2. QUALITATIVE AND QUANTITATIVE COMPOSITION

 Each ml contains

 Active substances:

Florfenicol 400MG

Meloxicam 5MG

Excipients.

For the full list of excipients, see section 6.1

 3. PHARMACEUTICAL FORM

 Solution for injection.

 Clear yellow solution.

4. CLINICAL PARTICULARS

 4.1 Target species

Cattle.

4.2 Indications for use, specifying the target species

 For therapeutic treatment of bovine respiratory disease (BRD) due to Histophilus somni, Mannheimia haemolytica, Pasteurella multocida and Mycoplasma bovisassociated with pyrexia.

4.3 Contraindications

 Do not use in adult bulls intended for breeding.

 Do not use in animals suffering from impaired hepatic, cardiac or renal function and haemorrhagic disorders, or when there is evidence of ulcerogenic gastrointestinal lesions. Do not use in case of hypersensitivity to the active substances or to any of the excipients.

 4.4 Special warnings for each target species

There is no bacterial eradication of Mycoplasma bovis. Clinical efficacy against M. bovis has only been demonstrated in mixed infections

View other products in Products »